JP2014535050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014535050A5 JP2014535050A5 JP2014537743A JP2014537743A JP2014535050A5 JP 2014535050 A5 JP2014535050 A5 JP 2014535050A5 JP 2014537743 A JP2014537743 A JP 2014537743A JP 2014537743 A JP2014537743 A JP 2014537743A JP 2014535050 A5 JP2014535050 A5 JP 2014535050A5
- Authority
- JP
- Japan
- Prior art keywords
- probe
- short
- sequence
- long
- genomic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 claims description 52
- 108091033319 polynucleotide Proteins 0.000 claims description 21
- 102000040430 polynucleotide Human genes 0.000 claims description 21
- 239000002157 polynucleotide Substances 0.000 claims description 21
- 238000009396 hybridization Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims 19
- 206010009944 Colon cancer Diseases 0.000 claims 8
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 8
- 208000026350 Inborn Genetic disease Diseases 0.000 claims 6
- 208000016361 genetic disease Diseases 0.000 claims 6
- 230000008707 rearrangement Effects 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 206010006187 Breast cancer Diseases 0.000 claims 4
- 208000026310 Breast neoplasm Diseases 0.000 claims 4
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 claims 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 4
- 101150110531 MLH1 gene Proteins 0.000 claims 4
- 101150033433 Msh2 gene Proteins 0.000 claims 4
- 206010033128 Ovarian cancer Diseases 0.000 claims 4
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 201000005202 lung cancer Diseases 0.000 claims 4
- 208000020816 lung neoplasm Diseases 0.000 claims 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 230000003252 repetitive effect Effects 0.000 claims 2
- 108091023043 Alu Element Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 208000018360 neuromuscular disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553889P | 2011-10-31 | 2011-10-31 | |
| US61/553,889 | 2011-10-31 | ||
| PCT/IB2012/002423 WO2013064896A1 (en) | 2011-10-31 | 2012-10-30 | Method for identifying or detecting genomic rearrangements in a biological sample |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014535050A JP2014535050A (ja) | 2014-12-25 |
| JP2014535050A5 true JP2014535050A5 (https=) | 2016-08-18 |
Family
ID=47559567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537743A Pending JP2014535050A (ja) | 2011-10-31 | 2012-10-30 | 生体試料におけるゲノム再編成を特定又は検出する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US9133514B2 (https=) |
| EP (1) | EP2773770A1 (https=) |
| JP (1) | JP2014535050A (https=) |
| WO (1) | WO2013064896A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013064895A1 (en) * | 2011-10-31 | 2013-05-10 | Genomic Vision | Methods for the detection, visualization and high resolution physical mapping of genomic rearrangements in breast and ovarian cancer genes and loci brca1 and brca2 using genomic morse code in conjunction with molecular combing |
| WO2016077750A1 (en) * | 2014-11-14 | 2016-05-19 | Athena Diagnostics, Inc. | Methods to detect a silent carrier genotype |
| CN110199031A (zh) * | 2016-11-29 | 2019-09-03 | 基因组影像公司 | 设计用于分析感兴趣的遗传区域中的特定事件的一组多核苷酸序列的方法 |
| EP3887552A1 (en) | 2018-11-30 | 2021-10-06 | Genomic Vision | Association between integration of viral as hpv or hiv genomes and the severity and/or clinical outcome of disorders as hpv associated cervical lesions or aids pathology |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2755149B1 (fr) * | 1996-10-30 | 1999-01-15 | Pasteur Institut | Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic |
| US6828097B1 (en) | 2000-05-16 | 2004-12-07 | The Childrens Mercy Hospital | Single copy genomic hybridization probes and method of generating same |
| US20030017159A1 (en) * | 2001-05-02 | 2003-01-23 | Jerome Ritz | Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| WO2005123961A2 (en) * | 2004-06-14 | 2005-12-29 | Ambry Genetics Corporation | Approaches to identifying mutations associated with hereditary nonpolyposis colorectal cancer |
| US7985542B2 (en) * | 2006-09-07 | 2011-07-26 | Institut Pasteur | Genomic morse code |
| JP2013524806A (ja) * | 2010-04-23 | 2013-06-20 | ゲノミク ビジョン | 分子コーミングを用いるゲノムdna及び感染性ウイルスdnaの検出によるウイルス感染の診断 |
-
2012
- 2012-10-30 JP JP2014537743A patent/JP2014535050A/ja active Pending
- 2012-10-30 EP EP12815761.7A patent/EP2773770A1/en not_active Ceased
- 2012-10-30 WO PCT/IB2012/002423 patent/WO2013064896A1/en not_active Ceased
- 2012-10-31 US US13/665,440 patent/US9133514B2/en active Active
-
2015
- 2015-08-03 US US14/816,397 patent/US20160032405A1/en not_active Abandoned
-
2017
- 2017-12-18 US US15/845,543 patent/US20180100202A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Del Vecchio et al. | Next-generation sequencing: recent applications to the analysis of colorectal cancer | |
| Dalgliesh et al. | Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes | |
| Stange et al. | Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15. 5 gain | |
| JP6700333B2 (ja) | ヘテロ接合性の消失(loss of heterozygosity)を評価するための方法および材料 | |
| Shibata et al. | Exploration of liver cancer genomes | |
| JP5843840B2 (ja) | 新しい癌マーカー | |
| Walker et al. | Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t (4; 14) and t (11; 14) myeloma | |
| Jiang et al. | Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis | |
| Lu et al. | Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24. 22-q24. 23 in medulloblastoma | |
| Sutton et al. | Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting | |
| Pitkänen et al. | Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer | |
| JP6709541B2 (ja) | 大腸癌に対する薬物療法の感受性を予測する方法 | |
| JP2021535489A5 (https=) | ||
| Iwakawa et al. | MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis | |
| Lionetti et al. | A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias | |
| JP2017523810A5 (https=) | ||
| Sun et al. | Extrachromosomal circular DNAs are common and functional in esophageal squamous cell carcinoma | |
| JP2012526563A5 (https=) | ||
| JP2014502155A (ja) | 癌関連の遺伝子または分子異常の検出 | |
| Onsongo et al. | CNV-RF is a random forest–based copy number variation detection method using next-generation sequencing | |
| JP2012503985A5 (https=) | ||
| Berg et al. | Genomic and prognostic heterogeneity among RAS/BRAF V600E/TP53 co‐mutated resectable colorectal liver metastases | |
| JP2014535050A5 (https=) | ||
| JP2019514344A (ja) | 癌のエピジェネティックプロファイリング | |
| Zhu et al. | A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer |